FDA
Date Range
Score Range
NBC News : Weight-loss drugs like GLP-1s are easy to buy online, raising overdose and safety concerns
Regulatory oversight is framed as insufficient and reactive rather than proactive
The article notes FDA warning letters and late regulatory actions, suggesting a lag in enforcement. It also highlights that adverse events are underreported and not systematically tracked.
“In a March 5 warning letter, the FDA accused drugmaker Novo Nordisk, the maker of Wegovy and Ozempic, of failing to report some adverse events to the federal government, including suicidal ideation and death.”
Daily Mail : The truth about peptides... what you MUST know about the trendy injections promoted as a …
FDA's regulatory stance framed as inconsistent or reactive rather than proactively protective
[contextualisation] and [proper_attribution]: The article notes the FDA banned peptides in 2023 but is now reconsidering access, suggesting regulatory uncertainty.
“In April 2026, the FDA announced plans to consider allowing some of them to be made to order at specialist pharmacies after banning them in 2023.”
The Washington Post : Why everyone’s suddenly talking about quitting antidepressants
Regulatory guidance framed as inadequate
[comprehensive_sourcing]: Repeated emphasis on lack of clear FDA or medical group guidance frames regulatory bodies as failing to provide necessary direction.
“Guidance on how to transition remains sparse. In the absence of clear direction from the Food and Drug Administration or major medical groups, the process is often left to guesswork.”
The Guardian : Health advocates warn government’s claims of baby formula safety contradict data
FDA is framed as downplaying risks despite contradictory internal evidence
[cherry_picking], [omission]
“Top FDA officials’ statements also appear to, in part, contradict a 2014 FDA paper that detailed how small amounts of the chemicals found in the current testing likely present a serious risk for newborns”
The Washington Post : White House prepares to replace FDA leader Marty Makary amid agency turmoil
FDA framed as in crisis due to leadership instability and internal turmoil
[framing_by_emphasis], [loaded_language]
“White House prepares to replace FDA leader Marty Makary amid agency turmoil”
Reuters : Exclusive: Kennedy's health officials explored US ban of some widely used antidepressants, sources say
FDA authority subtly questioned by highlighting limitations in banning approved drugs
The article explains the FDA cannot unilaterally ban approved drugs without new safety evidence, which contextualizes but also underscores constraints on its regulatory power, potentially undermining its authority in the reader’s mind.
“Experts in pharmaceutical regulation said the FDA doesn't have the authority to unilaterally impose a ban on medications that have already received U.S. approval”
The Washington Post : In a first, FDA authorizes fruit-flavored vapes for adults
FDA portrayed as responsive and scientifically rigorous in its regulatory decision-making
The article highlights the FDA's 'rigorous, scientific review' and quotes agency officials emphasizing technological safeguards, framing the agency as competent and proactive.
“By helping to prevent youth use, device access restrictions are a potential game changer,” Bret Koplow, acting director of the FDA’s Center for Tobacco Products, said in a statement.”
The New York Times : F.D.A. Blocked Publication of Research Finding Covid and Shingles Vaccines Were Safe
The actions of top FDA officials are framed as lacking scientific legitimacy and proper authority.
[omission], [editorializing]
“He did not address a question about the Shingrix safety study, which found the vaccine to be safe.”
The New York Times : F.D.A. Blocked Publication of Research Finding Covid and Shingles Vaccines Were Safe
The FDA is portrayed as engaging in scientific suppression and lacking integrity in its handling of vaccine safety research.
[loaded_language], [editorializing], [omission]
“He suggested that the request to pull the papers was an act of 'censorship.'”
Fox News : CVS disputes Planned Parenthood ‘strategic partnership’ claim as report language changes; critics push back
FDA oversight is framed as inadequate or uncertain
[misleading_context]: By highlighting ongoing review and adverse event reports without clarifying current regulatory stance, the FDA’s authority and decisiveness are undermined.
“Mifepristone also remains under federal scrutiny.”